European equities traded in the US as American depositary receipts were rising sharply late Thursday morning, up 1.24% to 1,928.04 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which advanced 10.9% and 5.2% respectively. They were followed by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which rose 4.6% and 4.1% respectively.

The decliners from continental Europe were led by brewing company Anheuser-Busch InBev (BUD) and oil and gas company Eni (E), which fell 1% and 0.7% respectively. They were followed by healthcare tech company Royal Philips (PHG), which was off 0.1% respectively.

The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biotech firm Trinity Biotech (TRIB), which increased 4% and 3.1% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were up 3% and 2.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 19.8% and 0.6% respectively. They were followed by medical device maker Smith & Nephew (SNN) and oil and gas company BP (BP), which lost 0.6% and 0.2% respectively.